menu search

PTE / PolarityTE (PTE) Stock: 1-For-25 Reverse Split Goes Into Effect

PolarityTE (PTE) Stock: 1-For-25 Reverse Split Goes Into Effect
A 1-for-25 reverse stock split of PolarityTE Inc (NASDAQ: PTE) has gone into effect. These are the details. Read More
Posted: May 17 2022, 07:02
Author Name: Pulse2
Views: 111413

PTE News  

PolarityTE (PTE) Stock: 1-For-25 Reverse Split Goes Into Effect

By Pulse2
May 17, 2022

PolarityTE (PTE) Stock: 1-For-25 Reverse Split Goes Into Effect

A 1-for-25 reverse stock split of PolarityTE Inc (NASDAQ: PTE) has gone into effect. These are the details. more_horizontal

Why Is PolarityTE Stock Up 85% Today?

By Benzinga
April 12, 2022

Why Is PolarityTE Stock Up 85% Today?

PolarityTE Inc (NASDAQ: PTE) shares are surging Tuesday as traders circle bullish commentary from a popular trader in the "FinTwit" community. "Fin more_horizontal

Top Penny Stocks to Buy? 3 As Stock Futures Climb Before Market Open

By PennyStocks
April 12, 2022

Top Penny Stocks to Buy? 3 As Stock Futures Climb Before Market Open

Here's what you need to know about buying penny stocks on April 12th The post Top Penny Stocks to Buy? 3 As Stock Futures Climb Before Market Open app more_horizontal

PolarityTE, Inc. (PTE) CEO Richard Hague on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 30, 2022

PolarityTE, Inc. (PTE) CEO Richard Hague on Q4 2021 Results - Earnings Call Transcript

PolarityTE, Inc. (PTE) CEO Richard Hague on Q4 2021 Results - Earnings Call Transcript more_horizontal

PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study

By Zacks Investment Research
January 19, 2022

PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study

PolarityTE (PTE) announces removal of clinical hold on a proposed pivotal study to evaluate its SkinTE for chronic cutaneous ulcers. PolarityTE plans more_horizontal

PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study

By Zacks Investment Research
January 19, 2022

PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study

PolarityTE (PTE) announces removal of clinical hold on a proposed pivotal study to evaluate its SkinTE for chronic cutaneous ulcers. PolarityTE plans more_horizontal

PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study

By Zacks Investment Research
January 19, 2022

PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study

PolarityTE (PTE) announces removal of clinical hold on a proposed pivotal study to evaluate its SkinTE for chronic cutaneous ulcers. PolarityTE plans more_horizontal

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PolarityTE, Inc. of Class Action Lawsuit and Upcoming Deadline - PTE

By Newsfile Corp
October 9, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PolarityTE, Inc. of Class Action Lawsuit and Upcoming Deadline - PTE

New York, New York--(Newsfile Corp. - October 9, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against PolarityTE, Inc. ( more_horizontal


Search within

Pages Search Results: